| | | | | | | | | | |
|
|
| Dockets Entered
On June 2, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| 2002P-0414
|
| Cefuroxime Axetil Tablets Oral suspension 125mg & 250mg ANDA
|
|
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
| 2004P-0206
|
| No abbreviated new drug application (ANDA) for Fluticasone Propionate Nasel Spray will be approval, unless it contains bioavailability and bioequivalence studies
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
14036
|
| Daxen, Inc.
|
| Vol #:
|
| 120
|
|
|
| LET
14037
|
| Source Naturals
|
| Vol #:
|
| 120
|
|
|
| LET
14038
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14039
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14040
|
| Flora, Inc.
|
| Vol #:
|
| 120
|
|
|
| LET
14041
|
| Hansen Beverage Company
|
| Vol #:
|
| 120
|
|
|
| LET
14042
|
| Lost Beverage Company
|
| Vol #:
|
| 120
|
|
|
| LET
14043
|
| Monster Beverage Company
|
| Vol #:
|
| 120
|
|
|
| LET
14044
|
| Blue Sky Beverage Company
|
| Vol #:
|
| 120
|
|
|
| LET
14045
|
| Monster Beverage Company
|
| Vol #:
|
| 120
|
|
|
| LET
14046
|
| Hansen Beverage Company
|
| Vol #:
|
| 120
|
|
|
| LET
14047
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14048
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14049
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14050
|
| Enzymatic Therapy
|
| Vol #:
|
| 121
|
|
|
| LET
14051
|
| Enzymatic Therapy
|
| Vol #:
|
| 121
|
|
|
| LET
14052
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14053
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14054
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14055
|
| Enzymatic Therapy
|
| Vol #:
|
| 120
|
|
|
| LET
14056
|
| Enzymatic Therapy
|
| Vol #:
|
| 121
|
|
|
| LET
14057
|
| Enzymatic Therapy
|
| Vol #:
|
| 121
|
|
|
| LET
14058
|
| Enzymatic Therapy
|
| Vol #:
|
| 121
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| EXB 52
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 53
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 54
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 55
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 56
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
| | | | | | | | |
|
|
| EXB 57
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 58
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 59
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 407
|
|
|
| EXB 60
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 61
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 62
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 63
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 64
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 65
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 66
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 67
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 68
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| EXB 69
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 408
|
|
|
| 2002P-0414
|
| Cefuroxime Axetil Tablets Oral suspension 125mg & 250mg ANDA
|
|
|
| ACK 2
|
| HFA-305 to The Weinberg Group Inc.
|
| Vol #:
|
| 1
|
|
|
| PRC 1
|
| The Weinberg Group Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
| APE 20
|
| Latinos Unidos Health Access Alliance & National Lulac Labor Advisor
|
| Vol #:
|
| 13
|
|
|
| APE 21
|
| Group Benefits Strategies
|
| Vol #:
|
| 13
|
|
|
| APE 22
|
| State of Wisconins
|
| Vol #:
|
| 14
|
|
|
| C
11
Cover
Letter, Appendix
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 11
|
|
|
| C
12
|
| Christensen, Miller, FInk, Jacobs, Glaser, Weil & Shapiro LLP
|
| Vol #:
|
| 11
|
|
|
| C
13
|
| King Pharmaceuticals, Inc
|
| Vol #:
|
| 13
|
|
|
| C
14
|
| American Academy of Pharmaceutical Physicians
|
| Vol #:
|
| 14
|
|
|
| C
15
|
| Schering-Plough Corporation
|
| Vol #:
|
| 13
|
|
|
| C
16
|
| Pacific Research Institute
|
| Vol #:
|
| 13
|
|
|
| C
17
|
| McKesson Corporation
|
| Vol #:
|
| 14
|
|
|
| C
18
|
| State of Minnesota
|
| Vol #:
|
| 14
|
|
|
| C
19
|
| Roy E Smythe
|
| Vol #:
|
| 14
|
|
|
| C
20
|
| NAMI (National Alliance for the Mentally Ill)
|
| Vol #:
|
| 14
|
|
|
| C
21
|
| American Society of Health-System Pharmacists
|
| Vol #:
|
| 14
|
|
|
| C 22
|
| Gary J Moss
|
| Vol #:
|
| 14
|
|
|
| C 23
|
| H Schouweiler
|
| Vol #:
|
| 14
|
|
|
| C 24
|
| D Cantor
|
| Vol #:
|
| 14
|
|
|
| C 25
|
| E Kaplan MD
|
| Vol #:
|
| 14
|
|
| | | | | | | |
|
|
| C
26
|
| Canadian International Pharmacy Association
|
| Vol #:
|
| 14
|
|
|
| C
27
|
| Hoffmann-La Roche Inc
|
| Vol #:
|
| 14
|
|
|
| EC
51
|
| Pharmaceutical Security Institute
|
| Vol #:
|
| 14
|
|
|
| EC
52
|
| Aurora Health Care
|
| Vol #:
|
| 14
|
|
|
| EC
53
|
| American Academy of Pharmaceutical Physicians
|
| Vol #:
|
| 14
|
|
|
| EC
54
|
| Dr. Jeffrey Greenberg
|
| Vol #:
|
| 14
|
|
|
| EMC
18
|
| Health Canada
|
| Vol #:
|
| 13
|
|
|
| EMC
19
|
| Healthcare Distribution Management Association
|
| Vol #:
|
| 14
|
|
|
| EMC
20
|
| Cancer Research and Prevention Foundation
|
| Vol #:
|
| 14
|
|
|
| LET
1
|
| State of Minnesota
|
| Vol #:
|
| 14
|
|
|
| LET
2
|
| University of Arizona Health Sciences Center
|
| Vol #:
|
| 14
|
|
|
| LET
3
|
| Congress of the United States
|
| Vol #:
|
| 14
|
|
|
| LET
4
|
| Goernment of Province of Quebec, Canada
|
| Vol #:
|
| 14
|
|
|
| LET
5
|
| Congress of the United States, House of Representatives
|
| Vol #:
|
| 14
|
|
|
| LET
6
|
| Health Canada
|
| Vol #:
|
| 14
|
|
|
| TR
4
|
| Transcript of the April 14, 2004 Public Meeting
|
| Vol #:
|
| 15
|
|
|
| TR
5
|
| Transcript of the April 27, 2004 Public Meeting (International and Academic Perspectives)
|
| Vol #:
|
| 16
|
|
|
| TR
6
|
| Transcript of the May 5, 2004 Health Care Purchasers
|
| Vol #:
|
| 17
|
|
|
| TR
7
Continued
|
| Transcript of the May 14, 2004
|
| Vol #:
|
| 18
|
|
|
| TS
56
|
| Barr Pharmaceuticals Inc
|
| Vol #:
|
| 13
|
|
|
| TS
57
|
| Biotechnology Industry Organization
|
| Vol #:
|
| 13
|
|
|
| TS
58
|
| Generic Pharmaceutical Association (GPhA)
|
| Vol #:
|
| 13
|
|
|
| TS
59
|
| Healthcare Distribution Management Association
|
| Vol #:
|
| 13
|
|
|
| TS
60
|
| National Association of Chain Drug Stores Inc
|
| Vol #:
|
| 13
|
|
|
| TS
61
|
| Pharmaceutical Distributors Association
|
| Vol #:
|
| 13
|
|
|
| TS
62
|
| Global Security, Pfizer Inc
|
| Vol #:
|
| 13
|
|
|
| TS
63
|
| Serona Inc
|
| Vol #:
|
| 13
|
|
|
| TS
64
|
| Authentix
|
| Vol #:
|
| 13
|
|
|
| TS
65
|
| Parents of Food Allergic Kids (POFAK)
|
| Vol #:
|
| 13
|
|
|
| TS
66
|
| Small Business Survival Committee
|
| Vol #:
|
| 13
|
|
|
| TS
67
|
| American Enterprise Institute
|
| Vol #:
|
| 24
|
|
|
| TS
68
|
| Patricia M Danzon PhD
|
| Vol #:
|
| 13
|
|
|
| TS
69
|
| Columbia University and National Bureau of Economic Research
|
| Vol #:
|
| 13
|
|
|
| TS
70
|
| National Association of Pharmacy Regulatory Authorities (NAPRA)
|
| Vol #:
|
| 13
|
|
|
| TS
71
|
| Vanderbilt University School of Medicine
|
| Vol #:
|
| 13
|
|
|
| TS
72
|
| Quebec Order of Pharmacists
|
| Vol #:
|
| 13
|
|
|
| TS
73
|
| Manitoba Pharmaceutical Association
|
| Vol #:
|
| 14
|
|